Insider Trading activities of Sangamo Therapeutics, Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sangamo Therapeutics, Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Sangamo Therapeutics, Inc since year 2005. Table 2 shows the detailed insider transactions of Sangamo Therapeutics, Inc since 2005. The reporting company's ticker symbol is SGMO. The reporting company's CIK number is 1001233.
The total value of stock buying since 2005 is $56,766,011.
The total value of stock sales since 2005 is $143,302,580.
The total value of stock option exercises since 2005 is $11,552,445.


 1   2   3   4 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Sangamo Therapeutics, Inc (SGMO).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-11 0 $0 5,000 $73,340 5,000 $25,150
2017-10 0 $0 15,000 $229,995 15,000 $118,455
2017-09 0 $0 46,000 $670,594 41,316 $243,359
2017-08 0 $0 11,474 $119,740 11,474 $46,769
2017-07 0 $0 15,000 $150,000 172 $686
2017-06 0 $0 2,000 $13,600 0 $0
2017-05 0 $0 2,639 $21,153 0 $0
2015-07 0 $0 37,000 $380,774 35,000 $204,999
2015-06 0 $0 69,200 $821,209 67,200 $342,555
2015-05 0 $0 70,000 $859,435 68,000 $347,935
2015-04 0 $0 69,200 $1,051,876 67,200 $343,347
2015-03 0 $0 95,701 $1,682,535 97,200 $708,452
2015-02 0 $0 79,200 $1,108,557 77,200 $418,922
2015-01 0 $0 84,200 $1,279,091 82,200 $524,202
2014-12 0 $0 81,354 $1,112,295 127,500 $449,745
2014-11 0 $0 67,000 $772,583 65,000 $305,675
2014-10 0 $0 67,000 $725,615 65,000 $315,305
2014-09 0 $0 67,000 $840,945 65,000 $319,805
2014-08 0 $0 112,770 $1,494,999 81,202 $383,655
2014-07 37,215 $456,218 480,257 $6,275,305 53,000 $278,420
2014-06 0 $0 2,737,276 $38,178,626 39,384 $248,982
2014-05 119,036 $1,421,330 980,697 $13,091,732 43,000 $243,395
2014-04 1,158,365 $17,133,007 780,893 $12,478,805 53,000 $332,890
2014-03 1,214,388 $24,236,520 1,048,708 $24,193,881 94,722 $483,054
2014-02 242,194 $4,557,949 273,196 $5,074,258 115,000 $554,000
2014-01 0 $0 170,773 $3,082,280 98,333 $517,414
2013-12 14,640 $176,996 100,000 $1,249,175 100,000 $539,600
2013-11 0 $0 65,000 $674,164 40,000 $152,115
2013-10 0 $0 75,000 $819,035 50,000 $205,945
2013-09 0 $0 72,278 $779,192 47,278 $175,392
2013-08 0 $0 65,000 $651,780 38,000 $152,379
2013-07 19,200 $187,891 890,444 $8,749,639 46,000 $171,699
2013-06 0 $0 3,000 $23,640 3,000 $10,350
2013-05 0 $0 21,000 $185,373 31,000 $99,350
2013-04 0 $0 36,190 $369,879 21,000 $74,850
2013-03 0 $0 21,000 $197,736 21,000 $83,670
2013-02 0 $0 56,000 $536,798 31,000 $118,170
2013-01 0 $0 24,600 $222,308 6,000 $29,520
2012-12 0 $0 56,000 $316,201 15,000 $54,150
2012-11 0 $0 34,736 $192,003 15,000 $54,150
2012-10 0 $0 46,000 $271,365 21,000 $83,670
2012-09 0 $0 30,000 $163,155 15,000 $54,150
2012-08 0 $0 20,000 $104,540 0 $0
2012-07 0 $0 35,000 $187,784 15,000 $54,150
2012-06 0 $0 15,000 $75,000 0 $0
2012-01 0 $0 15,000 $145,155 15,000 $54,150
2011-09 0 $0 2,500 $15,000 2,500 $7,500
2011-07 0 $0 19,000 $115,880 19,000 $72,510
2011-06 0 $0 19,000 $128,230 19,000 $72,510
2011-05 0 $0 19,000 $136,805 19,000 $72,510
2011-04 0 $0 27,433 $208,067 23,000 $89,895
2011-03 0 $0 2,500 $20,715 0 $0
2011-02 0 $0 6,388 $54,917 1,388 $2,831
2011-01 0 $0 2,500 $17,000 0 $0
2010-12 0 $0 45,834 $318,338 43,334 $121,398
2010-08 19,000 $57,050 0 $0 0 $0
2010-05 0 $0 2,500 $15,625 0 $0
2010-04 0 $0 2,500 $15,357 0 $0
2008-09 0 $0 1,000 $10,120 1,000 $3,000
2008-08 0 $0 36,000 $383,029 0 $0
2008-07 0 $0 54,200 $580,922 1,000 $4,920
2008-06 0 $0 25,000 $255,324 0 $0
2008-05 0 $0 41,000 $547,950 16,000 $82,770
2008-04 0 $0 28,300 $322,986 1,000 $4,920
2008-03 0 $0 101,700 $1,183,857 401,000 $72,920
2008-02 0 $0 45,200 $538,110 20,200 $101,922
2008-01 0 $0 45,000 $586,350 40,000 $183,750
2007-12 0 $0 41,100 $584,525 10,000 $47,175
2007-11 0 $0 107,000 $1,735,798 91,302 $472,896
2007-10 0 $0 25,000 $403,250 0 $0
2007-09 0 $0 30,000 $369,175 0 $0
2007-08 0 $0 30,000 $304,750 0 $0
2007-07 0 $0 30,000 $299,550 0 $0
2007-06 0 $0 35,000 $265,950 0 $0
2007-05 37,000 $267,120 25,000 $170,050 0 $0
2007-04 0 $0 25,000 $171,550 0 $0
2007-03 0 $0 25,000 $166,425 0 $0
2007-02 75,000 $639,998 33,000 $266,889 6,000 $19,200
2007-01 75,000 $558,000 25,000 $159,750 0 $0
2006-12 20,000 $150,800 64,917 $443,715 39,917 $171,187
2006-11 60,000 $467,400 25,000 $135,700 0 $0
2006-10 0 $0 25,000 $136,546 0 $0
2006-09 0 $0 25,000 $147,450 0 $0
2006-08 0 $0 25,000 $137,400 0 $0
2006-06 0 $0 14,000 $107,780 8,000 $24,000
2006-05 19,000 $125,590 25,000 $135,500 0 $0
2006-01 50,000 $233,800 0 $0 0 $0
2005-12 170,000 $690,200 0 $0 0 $0
2005-10 40,000 $182,600 0 $0 0 $0
2005-07 20,000 $80,000 0 $0 0 $0
2004-01 140,000 $941,200 0 $0 0 $0
2003-10 16,000 $80,000 0 $0 0 $0
2003-05 90,000 $323,099 0 $0 0 $0
2002-12 20,000 $95,800 0 $0 0 $0
2002-11 65,000 $253,599 0 $0 0 $0
2002-10 0 $0 5,000 $9,100 0 $0
2001-11 15,000 $126,514 0 $0 0 $0
2001-08 10,000 $101,100 0 $0 0 $0
2001-07 10,000 $149,900 0 $0 0 $0
2001-06 20,000 $282,100 0 $0 0 $0
2001-01 20,000 $446,800 0 $0 0 $0
2000-10 17,000 $530,060 0 $0 0 $0
2000-09 10,000 $450,850 0 $0 0 $0
2000-08 33,000 $1,362,520 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Sangamo Therapeutics, Inc insiders (SGMO)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-11-17 Ramasastry Saira (Director) Sale 5,000 14.67 73,340
2017-11-17 Ramasastry Saira (Director) Option Ex 5,000 5.03 25,150
2017-10-02 Herberts Curt A. Iii (Sr.VP & Chief Business Officer) Sale 15,000 15.33 229,995
2017-10-02 Herberts Curt A. Iii (Sr.VP & Chief Business Officer) Option Ex 15,000 7.90 118,455
2017-09-20 Ringo William R (Director) Sale 31,000 14.37 445,594
2017-09-20 Ringo William R (Director) Option Ex 31,000 6.05 187,550
2017-09-01 Herberts Curt A. Iii (Sr.VP & Chief Business Officer) Sale 15,000 15.00 225,000
2017-09-01 Herberts Curt A. Iii (Sr.VP & Chief Business Officer) Option Ex 10,316 5.41 55,809
2017-08-14 Herberts Curt A. Iii (Sr.VP & Chief Business Officer) Sale 5,000 11.00 55,000
2017-08-14 Herberts Curt A. Iii (Sr.VP & Chief Business Officer) Option Ex 5,000 5.12 25,600
2017-08-11 Herberts Curt A. Iii (Sr.VP & Chief Business Officer) Sale 6,474 10.00 64,740
2017-08-11 Herberts Curt A. Iii (Sr.VP & Chief Business Officer) Option Ex 6,474 3.27 21,169
2017-07-14 Herberts Curt A. Iii (Sr.VP & Chief Business Officer) Sale 15,000 10.00 150,000
2017-07-14 Herberts Curt A. Iii (Sr.VP & Chief Business Officer) Option Ex 172 3.99 686
2017-06-01 Herberts Curt A. Iii (Senior VP & CBO) Sale 2,000 6.80 13,600
2017-05-12 Herberts Curt A. Iii (Senior VP & CBO) Sale 2,000 8.50 17,000
2017-05-11 Herberts Curt A. Iii (Senior VP & CBO) Sale 639 6.50 4,153
2015-07-15 Lanphier Edward O Ii (President & CEO) Sale 25,000 10.43 260,774
2015-07-15 Lanphier Edward O Ii (President & CEO) Option Ex 25,000 6.82 170,500
2015-07-13 Wolff Henry Ward (Exec VP & CFO) Sale 5,898 10.00 58,980
2015-07-13 Wolff Henry Ward (Exec VP & CFO) Option Ex 3,898 3.45 13,448
2015-07-10 Wolff Henry Ward (Exec VP & CFO) Sale 6,102 10.00 61,020
2015-07-10 Wolff Henry Ward (Exec VP & CFO) Option Ex 6,102 3.45 21,051
2015-06-15 Lanphier Edward O Ii (President & CEO) Sale 25,000 11.08 277,075
2015-06-15 Lanphier Edward O Ii (President & CEO) Option Ex 25,000 6.82 170,500
2015-06-10 Wolff Henry Ward (Exec VP & CFO) Sale 12,000 12.21 146,556
2015-06-10 Wolff Henry Ward (Exec VP & CFO) Option Ex 10,000 3.45 34,500
2015-06-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 12.29 184,395
2015-06-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 3.45 51,750
2015-06-03 Ringo William R Sale 2,200 12.44 27,363
2015-06-03 Ringo William R Option Ex 2,200 6.05 13,310
2015-06-01 Gregory Philip D (SVP of Research & CSO) Sale 15,000 12.39 185,820
2015-06-01 Gregory Philip D (SVP of Research & CSO) Option Ex 15,000 4.83 72,495
2015-05-15 Lanphier Edward O Ii (President & CEO) Sale 25,000 11.52 287,875
2015-05-15 Lanphier Edward O Ii (President & CEO) Option Ex 25,000 6.82 170,500
2015-05-11 Wolff Henry Ward (Exec VP & CFO) Sale 12,000 13.25 158,952
2015-05-11 Wolff Henry Ward (Exec VP & CFO) Option Ex 10,000 3.45 34,500
2015-05-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 12.29 184,305
2015-05-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 3.45 51,750
2015-05-04 Ringo William R Sale 3,000 12.98 38,928
2015-05-04 Ringo William R Option Ex 3,000 6.23 18,690
2015-05-01 Gregory Philip D (SVP of Research & CSO) Sale 15,000 12.62 189,375
2015-05-01 Gregory Philip D (SVP of Research & CSO) Option Ex 15,000 4.83 72,495
2015-04-15 Lanphier Edward O Ii (President & CEO) Sale 25,000 15.33 383,250
2015-04-15 Lanphier Edward O Ii (President & CEO) Option Ex 25,000 6.82 170,500
2015-04-10 Wolff Henry Ward (Exec VP & CFO) Sale 12,000 15.37 184,380
2015-04-10 Wolff Henry Ward (Exec VP & CFO) Option Ex 10,000 3.45 34,500
2015-04-06 Ringo William R Sale 2,200 14.95 32,881
2015-04-06 Ringo William R Option Ex 2,200 6.41 14,102
2015-04-06 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 14.95 224,175
2015-04-06 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 3.45 51,750
2015-04-01 Gregory Philip D (SVP of Research & CSO) Sale 15,000 15.15 227,190
2015-04-01 Gregory Philip D (SVP of Research & CSO) Option Ex 15,000 4.83 72,495
2015-03-19 Wolff Henry Ward (Exec VP & CFO) Sale 10,000 18.00 180,000
2015-03-19 Wolff Henry Ward (Exec VP & CFO) Option Ex 10,000 14.27 142,700
2015-03-16 Lanphier Edward O Ii (President & CEO) Sale 25,000 17.29 432,300
2015-03-16 Lanphier Edward O Ii (President & CEO) Option Ex 25,000 6.82 170,500
2015-03-10 Wolff Henry Ward (Exec VP & CFO) Sale 12,000 16.68 200,196
2015-03-10 Wolff Henry Ward (Exec VP & CFO) Option Ex 10,000 3.45 34,500
2015-03-05 Mento Steven J Sale 6,501 18.30 118,942
2015-03-05 Mento Steven J Option Ex 10,000 4.54 45,400
2015-03-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 18.29 274,290
2015-03-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 3.45 51,750
2015-03-04 Wolff Henry Ward (Exec VP & CFO) Sale 10,000 18.00 180,000
2015-03-04 Wolff Henry Ward (Exec VP & CFO) Option Ex 10,000 14.27 142,700
2015-03-03 Ringo William R Sale 2,200 17.21 37,862
2015-03-03 Ringo William R Option Ex 2,200 6.41 14,102
2015-03-02 Gregory Philip D (SVP of Research & CSO) Sale 15,000 17.26 258,945
2015-03-02 Gregory Philip D (SVP of Research & CSO) Option Ex 15,000 7.12 106,800
2015-02-17 Lanphier Edward O Ii (President & CEO) Sale 25,000 15.69 392,150
2015-02-17 Lanphier Edward O Ii (President & CEO) Option Ex 25,000 6.82 170,500
2015-02-12 Ramasastry Saira Sale 10,000 15.00 150,000
2015-02-12 Ramasastry Saira Option Ex 10,000 5.03 50,300
2015-02-10 Wolff Henry Ward (Exec VP & CFO) Sale 12,000 12.64 151,692
2015-02-10 Wolff Henry Ward (Exec VP & CFO) Option Ex 10,000 3.45 34,500
2015-02-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 12.93 193,950
2015-02-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 5.13 77,025
2015-02-03 Ringo William R Sale 2,200 12.70 27,940
2015-02-03 Ringo William R Option Ex 2,200 6.41 14,102
2015-02-02 Gregory Philip D (SVP of Research & CSO) Sale 15,000 12.86 192,825
2015-02-02 Gregory Philip D (SVP of Research & CSO) Option Ex 15,000 4.83 72,495
2015-01-16 Lanphier Edward O Ii (President & CEO) Sale 10,000 14.29 142,850
2015-01-16 Lanphier Edward O Ii (President & CEO) Option Ex 10,000 6.82 68,200
2015-01-15 Lanphier Edward O Ii (President & CEO) Sale 15,000 14.53 217,935
2015-01-15 Lanphier Edward O Ii (President & CEO) Option Ex 15,000 6.82 102,300
2015-01-12 Wolff Henry Ward (Exec VP & CFO) Sale 12,000 15.87 190,452
2015-01-12 Wolff Henry Ward (Exec VP & CFO) Option Ex 10,000 3.45 34,500
2015-01-05 Ringo William R Sale 2,200 15.20 33,429
2015-01-05 Ringo William R Option Ex 2,200 6.41 14,102
2015-01-05 Larson John William Sale 15,000 15.10 226,545
2015-01-05 Larson John William Option Ex 15,000 6.40 96,000
2015-01-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 15.41 231,210
2015-01-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 6.82 102,300
2015-01-02 Gregory Philip D (SVP, Research & CSO) Sale 15,000 15.78 236,670
2015-01-02 Gregory Philip D (SVP, Research & CSO) Option Ex 15,000 7.12 106,800
2014-12-15 Larson John William (Director) Sale 10,000 16.28 162,830
2014-12-15 Larson John William (Director) Option Ex 15,000 5.72 85,800
2014-12-15 Lanphier Edward O Ii (President & CEO) Sale 25,000 15.63 390,775
2014-12-15 Lanphier Edward O Ii (President & CEO) Option Ex 25,000 4.11 102,750
2014-12-11 Mento Steven J (Director) Sale 6,354 15.00 95,310
2014-12-11 Mento Steven J (Director) Option Ex 10,000 4.10 41,000
2014-12-11 Wolff Henry Ward (Exec VP & CFO) Option Ex 37,500 .00 0
2014-12-09 Larson John William (Director) Sale 10,000 12.00 120,000
2014-12-09 Larson John William (Director) Option Ex 10,000 4.54 45,400
2014-12-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 11.21 168,195
2014-12-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 6.82 102,300
2014-12-01 Gregory Philip D (SVP of Research & CSO) Sale 15,000 11.68 175,185
2014-12-01 Gregory Philip D (SVP of Research & CSO) Option Ex 15,000 4.83 72,495
2014-11-17 Lanphier Edward O Ii (President & CEO) Sale 25,000 11.23 280,850
2014-11-17 Lanphier Edward O Ii (President & CEO) Option Ex 25,000 4.11 102,750
2014-11-12 Larson John William (Director) Sale 10,000 12.00 120,010
2014-11-12 Larson John William (Director) Option Ex 10,000 4.10 41,000
2014-11-10 Wolff Henry Ward (Exec VP & CFO) Sale 2,000 11.37 22,748
2014-11-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 11.35 170,265
2014-11-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 5.46 81,975
2014-11-03 Gregory Philip D (SVP of Research & CSO) Sale 15,000 11.91 178,710
2014-11-03 Gregory Philip D (SVP of Research & CSO) Option Ex 15,000 5.33 79,950
2014-10-28 Larson John William (Director) Sale 10,000 12.02 120,150
2014-10-28 Larson John William (Director) Option Ex 10,000 7.28 72,800
2014-10-15 Lanphier Edward O Ii (President & CEO) Sale 25,000 10.49 262,375
2014-10-15 Lanphier Edward O Ii (President & CEO) Option Ex 25,000 4.11 102,750
2014-10-10 Wolff Henry Ward (Exec VP & CFO) Sale 2,000 10.10 20,200
2014-10-06 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 10.72 160,860
2014-10-06 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 4.11 61,650
2014-10-01 Gregory Philip D (SVP of Research & CSO) Sale 15,000 10.80 162,030
2014-10-01 Gregory Philip D (SVP of Research & CSO) Option Ex 15,000 5.21 78,105
2014-09-15 Lanphier Edward O Ii (President & CEO) Sale 25,000 12.13 303,375
2014-09-15 Lanphier Edward O Ii (President & CEO) Option Ex 25,000 4.11 102,750
2014-09-10 Wolff Henry Ward (Exec VP & CFO) Sale 2,000 12.31 24,620
2014-09-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 12.21 183,075
2014-09-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 4.11 61,650
2014-09-04 Larson John William (Director) Sale 10,000 12.81 128,080
2014-09-04 Larson John William (Director) Option Ex 10,000 7.73 77,300
2014-09-02 Gregory Philip D (SVP of Research & CSO) Sale 15,000 13.45 201,795
2014-09-02 Gregory Philip D (SVP of Research & CSO) Option Ex 15,000 5.21 78,105
2014-08-15 Lanphier Edward O Ii (President & CEO) Sale 25,000 13.95 348,800
2014-08-15 Lanphier Edward O Ii (President & CEO) Option Ex 25,000 4.11 102,750
2014-08-11 Wolff Henry Ward (Exec VP & CFO) Sale 10,000 14.16 141,590
2014-08-11 Wolff Henry Ward (Exec VP & CFO) Option Ex 8,000 7.28 58,240
2014-08-08 Ramasastry Saira (Director) Sale 10,000 14.00 140,000
2014-08-08 Ramasastry Saira (Director) Option Ex 10,000 5.03 50,300
2014-08-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 12.99 194,790
2014-08-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 13,202 4.11 54,260
2014-08-04 Larson John William (Director) Sale 10,000 12.56 125,580
2014-08-04 Larson John William (Director) Option Ex 10,000 4.00 40,000
2014-08-01 Kolchinsky Peter Sale 27,770 12.82 356,094
2014-08-01 Gregory Philip D (SVP of Research & CSO) Sale 15,000 12.54 188,145
2014-08-01 Gregory Philip D (SVP of Research & CSO) Option Ex 15,000 5.21 78,105
2014-07-30 Kolchinsky Peter Sale 109,590 12.44 1,362,751
2014-07-29 Kolchinsky Peter Sale 1,407 12.41 17,463
 1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of SGMO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sangamo Therapeutics, Inc (symbol SGMO, CIK number 1001233) see the Securities and Exchange Commission (SEC) website.